Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression DD Belke, S Betuing, MJ Tuttle, C Graveleau, ME Young, M Pham, ... The Journal of clinical investigation 109 (5), 629-639, 2002 | 498 | 2002 |
Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers JM Peyrin, B Deleglise, L Saias, M Vignes, P Gougis, S Magnifico, ... Lab on a Chip 11 (21), 3663-3673, 2011 | 292 | 2011 |
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease L Boussicault, S Alves, A Lamazière, A Planques, N Heck, L Moumné, ... Brain 139 (3), 953-970, 2016 | 165 | 2016 |
Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse K Brami‐Cherrier, E Roze, JA Girault, S Betuing, J Caboche Journal of neurochemistry 108 (6), 1323-1335, 2009 | 162 | 2009 |
Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus D Charvin, C Cifuentes-Diaz, N Fonknechten, V Joshi, J Hazan, J Melki, ... Human molecular genetics 12 (1), 71-78, 2003 | 108 | 2003 |
Mitogen‐and stress‐activated protein kinase‐1 deficiency is involved in expanded‐huntingtin‐induced transcriptional dysregulation and striatal death E Roze, S Bettuing, C Deyts, E Marcon, K Brami‐Cherrier, C Pages, ... The FASEB Journal 22 (4), 1083-1093, 2008 | 96 | 2008 |
Multiple aspects of gene dysregulation in Huntington’s disease L Moumné, S Betuing, J Caboche Frontiers in neurology 4, 54936, 2013 | 93 | 2013 |
CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease R Kacher, A Lamazière, N Heck, V Kappes, C Mounier, G Despres, ... Brain 142 (8), 2432-2450, 2019 | 89 | 2019 |
Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation C Deyts, B Galan-Rodriguez, E Martin, N Bouveyron, E Roze, D Charvin, ... PloS one 4 (12), e8287, 2009 | 71 | 2009 |
Mitogen-and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter E Martin, S Betuing, C Pagès, K Cambon, G Auregan, N Deglon, E Roze, ... Human Molecular Genetics 20 (12), 2422-2434, 2011 | 66 | 2011 |
Huntington’s disease E Roze, C Bonnet, S Betuing, J Caboche Diseases of DNA Repair, 45-63, 2010 | 66 | 2010 |
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo D Charvin, E Roze, V Perrin, C Deyts, S Betuing, C Pagès, E Régulier, ... Neurobiology of disease 29 (1), 22-29, 2008 | 63 | 2008 |
A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington’s disease N Heck, S Betuing, P Vanhoutte, J Caboche Brain Structure and Function 217, 421-434, 2012 | 49 | 2012 |
Huntington’s disease and striatal signaling E Roze, E Cahill, E Martin, C Bonnet, P Vanhoutte, S Betuing, J Caboche Frontiers in neuroanatomy 5, 55, 2011 | 48 | 2011 |
Rapid synaptogenesis in the nucleus accumbens is induced by a single cocaine administration and stabilized by mitogen-activated protein kinase interacting kinase-1 activity M Dos Santos, M Salery, B Forget, MAG Perez, S Betuing, T Boudier, ... Biological psychiatry 82 (11), 806-818, 2017 | 32 | 2017 |
Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes ED Abel, C Graveleau, S Betuing, M Pham, PA Reay, V Kandror, ... Molecular Endocrinology 18 (10), 2491-2501, 2004 | 32 | 2004 |
Altered cholesterol homeostasis in Huntington’s disease R Kacher, C Mounier, J Caboche, S Betuing Frontiers in aging neuroscience 14, 797220, 2022 | 30 | 2022 |
Gβγ-independent coupling of α2-adrenergic receptor to p21rhoA in preadipocytes S Bétuing, D Daviaud, C Pagès, E Bonnard, P Valet, M Lafontan, ... Journal of Biological Chemistry 273 (25), 15804-15810, 1998 | 28 | 1998 |
Functional consequences of constitutively active α2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes S Bétuing, P Valet, S Lapalu, D Peyroulan, G Hickson, D Daviaud, ... Biochemical and biophysical research communications 235 (3), 765-773, 1997 | 28 | 1997 |
alpha2-Adrenoceptor stimulation promotes actin polymerization and focal adhesion in 3T3F442A and BFC-1beta preadipocytes S Bétuing, D Daviaud, P Valet, A Bouloumie, M Lafontan, ... Endocrinology 137 (12), 5220-5229, 1996 | 25 | 1996 |